Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Days Sales Outstanding : 84.84 (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Sun Pharmaceuticals Industries Days Sales Outstanding?

Sun Pharmaceuticals Industries's average Accounts Receivable for the three months ended in Dec. 2023 was ₹113,027 Mil. Sun Pharmaceuticals Industries's Revenue for the three months ended in Dec. 2023 was ₹121,569 Mil. Hence, Sun Pharmaceuticals Industries's Days Sales Outstanding for the three months ended in Dec. 2023 was 84.84.

The historical rank and industry rank for Sun Pharmaceuticals Industries's Days Sales Outstanding or its related term are showing as below:

NSE:SUNPHARMA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 5.32 Med: 93.12 Max: 106.24
Current: 91.09

During the past 13 years, Sun Pharmaceuticals Industries's highest Days Sales Outstanding was 106.24. The lowest was 5.32. And the median was 93.12.

NSE:SUNPHARMA's Days Sales Outstanding is ranked worse than
67.87% of 999 companies
in the Drug Manufacturers industry
Industry Median: 72.3 vs NSE:SUNPHARMA: 91.09

Sun Pharmaceuticals Industries's Days Sales Outstanding declined from Dec. 2022 (100.30) to Dec. 2023 (84.84).

Sun Pharmaceuticals Industries Days Sales Outstanding Historical Data

The historical data trend for Sun Pharmaceuticals Industries's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharmaceuticals Industries Days Sales Outstanding Chart

Sun Pharmaceuticals Industries Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

106.24

103.35

101.50

93.34

92.90

Sun Pharmaceuticals Industries Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															100.30	97.32	88.57	85.92	84.84

Competitive Comparison of Sun Pharmaceuticals Industries's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharmaceuticals Industries's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sun Pharmaceuticals Industries's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharmaceuticals Industries's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Sun Pharmaceuticals Industries's Days Sales Outstanding falls into.

Sun Pharmaceuticals Industries Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Sun Pharmaceuticals Industries's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (105928.9	+	114385.1)	/	2 )	/	432788.7	*	365
=	110157					/	432788.7	*	365
=	92.90

Sun Pharmaceuticals Industries's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (113026.5	+	0)	/	1 )	/	121568.6	*	365 / 4
=	113026.5					/	121568.6	*	365 / 4
=	84.84

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Sun Pharmaceuticals Industries Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Sun Pharmaceuticals Industries's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

524715:India

Address

Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063

Website

https://www.sunpharma.com

Sun Pharmaceuticals Industries Ltd is India's largest generic pharmaceutical manufacturer and the fourth largest in the world. The company's largest markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is primarily based in India.

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Headlines

No Headlines